
Qt Med Pharmaceuticals Private Limited
Founded in 2024 and headquartered in Andhra Pradesh, India.
Founded in 2024 and headquartered in Andhra Pradesh, India.
Qt Med Pharmaceuticals Private Limited (QMPPL) is a Private Limited Indian Non-Government Company incorporated in India on 27 December 2024 ( two months 8 days old ). Its registered office is in Vizianagaram, Andhra Pradesh, India.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Ganesh Patri and Ramalingeswara Vijjapu serve as directors at the Company.
Vizianagaram, Andhra Pradesh, India
+91-XXXXXXXXXX
-
U46497AP2024PTC117189
117189
Private Limited Indian Non-Government Company
27 Dec 2024
-
-
Unlisted
Roc-Vijayawada
Name | Designation | Appointment Date | Status |
---|---|---|---|
Ganesh Patri ![]() | Director | 27-Dec-2024 | Current |
Ramalingeswara Vijjapu | Director | 27-Dec-2024 | Current |
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
Unlock access to Qt Med Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Ganesh Patri is a mutual person
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Qt Med Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Qt Med Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Qt Med Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Ganesh Kumar Patri was appointed as a Director was appointed as a Director on 27 Dec 2024 & has been associated with this company since 2 months 8 days .
Ramalingeswara Rao Vijjapu was appointed as a Director was appointed as a Director on 27 Dec 2024 & has been associated with this company since 2 months 8 days .
Qt Med Pharmaceuticals Private Limited was registered on 27 Dec 2024 with RoC-Vijayawada & aged 2 months 8 days as per MCA records.
Qt Med Pharmaceuticals Private Limited was incorporated on 27 Dec 2024.
The authorized share capital of Qt Med Pharmaceuticals Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.
Currently 2 directors are associated with Qt Med Pharmaceuticals Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Qt Med Pharmaceuticals Private Limited is Flat No-Ff1 Thotapalem, Vizianagaram, Andhra Pradesh, India, 535002.
The corporate identification number (CIN) of Qt Med Pharmaceuticals Private Limited is U46497AP2024PTC117189 and the company number is 117189 as per Ministry of Corporate Affairs (MCA).